Pharmaceuticals

Sanofi in pact to acquire US biotech haemophila drugs maker Bioverativ for 11.6 bn

22 Jan 2018

Biocon, Sandoz ink global pact for immunology, oncology biosimilar

19 Jan 2018

Both companies will share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products and will have a cost and profit share arrangement globally

Pfizer to end Alzheimer, Parkinson research; patients disappointed

17 Jan 2018

Celgene Corp in talks to buy Juno Therapeutics

17 Jan 2018

In urban streams, pharmaceutical pollution is driving microbial resistance

11 Jan 2018

Pfizer to end research to develop new drugs for Alzheimer’s and Parkinson’s disease

09 Jan 2018

Celgene to Acquire Impact Biomedicines for upto $7 bn

08 Jan 2018

Luxturna gene therapy to cure rare blindness

05 Jan 2018

Bharat Biotech scores big with WHO-approved typhoid vaccine

04 Jan 2018

Typbar TCV, a fourth generation vaccine against typhoid disease, has proven to provide long term protection against typhoid to both adults and children below 2 years of age

Price of cancer drug Lomustine hiked 1400 per cent since 2013

29 Dec 2017

Martin Shkreli’s former company lawyer convicted for fraud

28 Dec 2017

Opioid crisis hits US life expectancy

23 Dec 2017

N Carolina sues pharma company over opioid marketing campaign

22 Dec 2017

Roche to acquire US biotech firm Ignyta for $1.7 billion

22 Dec 2017

Indian firm gets regulator’s nod to start Zika vaccine trials

19 Dec 2017

Drugmaker Sanofi under fire over Dengvaxia reverse

18 Dec 2017

US pharma industry challenges California's transparency legislation

09 Dec 2017

Stryker Corp to buy Entellus Medical for $662 mn

08 Dec 2017

Gilead Sciences to buy Cell Design Labs for up to $567 mn

08 Dec 2017

Walgreens' Boots Alliance buys 40% in Sinopharm Holding GuoDa Drugstores for $418 mn

07 Dec 2017

Nestle to buy Canadian vitamin maker Atrium for $2.3 bn

07 Dec 2017

Swiss food and drink giant Nestle SA yesterday struck a deal to buy Canadian privately-held vitamin maker Atrium Innovations for $2.3 billion in order to expand its consumer healthcare portfolio

Over 10% of medical products spurious; poor nations worst hit: WHO

06 Dec 2017

WHO to review Sanofi’s dengue vaccine Dengvaxia over safety concerns

05 Dec 2017

The review comes after the French pharma giant’s own admission that its dengue vaccine could have unintended consequences in patients who had never been infected with the mosquito-borne virus and the Philippines halted its use

TPG Capital raises buyout offer for medical device maker Exactech to $737 mn

05 Dec 2017

Commons committee head warns Brexit may push up cost of medicines in the UK

04 Dec 2017